Koers Puma Biotechnology Inc OTC Bulletin Board
Aandelen
PBYI
US74587V1070
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 219 mln. 205 mln. | Omzet 2025 * | 225 mln. 210 mln. | Marktkapitalisatie | 150 mln. 140 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10 mln. 9,34 mln. | Nettowinst (verlies) 2025 * | 15 mln. 14,02 mln. | EV/omzet 2024 * | 0,69 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,67 x |
K/w-verhouding 2024 * |
12,9
x | K/w-verhouding 2025 * |
12,8
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,6% |
Recentste transcriptie over Puma Biotechnology Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15-09-10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05-11-18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-03-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23-02-18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27-04-12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15-09-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |